Cancer Research Meeting Calendar Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshidome, K.
Right arrow Articles by Green, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshidome, K.
Right arrow Articles by Green, J. E.
[Cancer Research 60, 6901-6910, December 15, 2000]
© 2000 American Association for Cancer Research

Regular Articles

Estrogen Promotes Mammary Tumor Development in C3(1)/SV40 Large T-Antigen Transgenic Mice: Paradoxical Loss of Estrogen Receptor{alpha} Expression during Tumor Progression

Katsuhide Yoshidome1, Masa-Aki Shibata2, Christine Couldrey, Kenneth S. Korach and Jeffrey E. Green3

Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, NIH, Institutes of Health, Bethesda, Maryland 20892 [K. Y., M-A. S., C. C., J. E. G.], and Receptor Biology Section, Laboratory of Reproduction and Developmental Toxicology, National Institute of Environmental Health Science, National Institute of Health Sciences, NIH, Research Triangle Park, North Carolina 27709 [K. S. K.]

Although several lines of epidemiological evidence suggest that estrogen exposure influences the incidence of breast cancer development, the mechanisms by which estrogen may stimulate the formation of breast cancer remain poorly understood. We have explored how alterations in estrogen exposure can influence the development of mammary cancer in the C3(1)/TAG transgenic model, where estrogen levels and estrogen receptor {alpha} (ER{alpha}) expression do not appear to modify the level of transgene expression. The C3(1)/TAG transgene becomes transcriptionally active in mammary ductal target cells at 3 weeks of age after the estrogen-induced differentiation of the mammary epithelial anlage to the ductal outgrowth stage. Complete maturation of the mammary ductal tree, however, is not required for cancer development because tumors arise in animals where ductal branching and terminal end bud formation have been prematurely arrested by ovariectomy. Mammary tumorigenesis in this model is promoted by increased estrogen exposure with the development of significantly more mammary intraepithelial neoplastic lesions and carcinomas associated with accelerated malignant conversion. The promotion of mammary tumors in this model appears to occur through an estrogen-induced proliferation and increase in the number of available target cells for transformation at the terminal ductal lobular units, as has been postulated to occur in women who receive hormone replacement therapy and/or by additional molecular mechanisms. We show, for the first time in a transgenic mouse model, that mammary tumor progression is associated with the loss of ER{alpha} expression, as has been often observed in human breast cancers with important clinical significance. Estrogen signaling may, therefore, serve different functions, depending upon the stage of tumorigenesis. ERß expression is up-regulated during tumor progression, although the functional significance of this remains to be determined.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
L. M Arendt, L. C Evans, D. E Rugowski, M. J. Garcia-Barchino, H. Rui, and L. A Schuler
Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes
J. Endocrinol., October 1, 2009; 203(1): 99 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
J. B. Williams, D. Pang, B. Delgado, M. Kocherginsky, M. Tretiakova, T. Krausz, D. Pan, J. He, M. K. McClintock, and S. D. Conzen
A Model of Gene-Environment Interaction Reveals Altered Mammary Gland Gene Expression and Increased Tumor Growth following Social Isolation
Cancer Prevention Research, October 1, 2009; 2(10): 850 - 861.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
T. A. Rose-Hellekant, A. J. Skildum, O. Zhdankin, A. L. Greene, R. R. Regal, K. D. Kundel, and D. W. Kundel
Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor-Positive/Progesterone Receptor-Negative Mammary Tumors
Cancer Prevention Research, May 1, 2009; 2(5): 496 - 502.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
D. Medina, F. Kittrell, J. Hill, Y. Zhang, S. G. Hilsenbeck, R. Bissonette, and P. H. Brown
Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib
Cancer Prevention Research, February 1, 2009; 2(2): 168 - 174.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Zhang, R. G. Mehta, D. D. Lantvit, K. T. Coschigano, J. J. Kopchick, J. E. Green, S. Hedayat, K. T. Christov, V. H. Ray, T. G. Unterman, et al.
Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling
Carcinogenesis, January 1, 2007; 28(1): 143 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Woditschka, J. D. Haag, J. L. Waller, D. M. Monson, A. A. Hitt, H. L. Brose, R. Hu, Y. Zheng, P. A. Watson, K. Kim, et al.
Neu-Induced Retroviral Rat Mammary Carcinogenesis: A Novel Chemoprevention Model for Both Hormonally Responsive and Nonresponsive Mammary Carcinomas.
Cancer Res., July 1, 2006; 66(13): 6884 - 6891.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
Y. Wang, K. W. Lee, F. L. Chan, S. Chen, and L. K. Leung
The Red Wine Polyphenol Resveratrol Displays Bilevel Inhibition on Aromatase in Breast Cancer Cells
Toxicol. Sci., July 1, 2006; 92(1): 71 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J.-I. Huh, A. Calvo, R. Charles, and J. E. Green
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with id-1 expression.
Cancer Res., April 1, 2006; 66(7): 3495 - 3503.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. M. Arendt, T. A. Rose-Hellekant, E. P. Sandgren, and L. A. Schuler
Prolactin Potentiates Transforming Growth Factor {alpha} Induction of Mammary Neoplasia in Transgenic Mice
Am. J. Pathol., April 1, 2006; 168(4): 1365 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Medina, F. S. Kittrell, J. Hill, A. Shepard, G. Thordarson, and P. Brown
Tamoxifen Inhibition of Estrogen Receptor-{alpha}-Negative Mouse Mammary Tumorigenesis
Cancer Res., April 15, 2005; 65(8): 3493 - 3496.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Liu, S. Varghese, and S. D. Rabkin
Oncolytic Herpes Simplex Virus Vector Therapy of Breast Cancer in C3(1)/SV40 T-antigen Transgenic Mice
Cancer Res., February 15, 2005; 65(4): 1532 - 1540.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. V. Desai, A. M. Michalowska, P. Kondaiah, J. M. Ward, J. H. Shih, and J. E. Green
Gene Expression Profiling Identifies a Unique Androgen-Mediated Inflammatory/Immune Signature and a PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10)-Mediated Apoptotic Response Specific to the Rat Ventral Prostate
Mol. Endocrinol., December 1, 2004; 18(12): 2895 - 2907.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-C. J. Lin, K.-F. Lee, A. Yu. Nikitin, S. G. Hilsenbeck, R. D. Cardiff, A. Li, K.-W. Kang, S. A. Frank, W.-H. Lee, and E. Y-H. P. Lee
Somatic Mutation of p53 Leads to Estrogen Receptor {alpha}-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis
Cancer Res., May 15, 2004; 64(10): 3525 - 3532.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. Kavanaugh and J. E. Green
The Use of Genetically Altered Mice for Breast Cancer Prevention Studies
J. Nutr., July 1, 2003; 133(7): 2404S - 2409.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Medina, F. S. Kittrell, A. Shepard, A. Contreras, J. M. Rosen, and J. Lydon
Hormone Dependence in Premalignant Mammary Progression
Cancer Res., March 1, 2003; 63(5): 1067 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. V. Desai, N. Xiao, W. Wang, L. Gangi, J. Greene, J. I. Powell, R. Dickson, P. Furth, K. Hunter, R. Kucherlapati, et al.
Initiating oncogenic event determines gene-expression patterns of human breast cancer models
PNAS, May 14, 2002; 99(10): 6967 - 6972.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. C. Hewitt, W. P. Bocchinfuso, J. Zhai, C. Harrell, L. Koonce, J. Clark, P. Myers, and K. S. Korach
Lack of Ductal Development in the Absence of Functional Estrogen Receptor {alpha} Delays Mammary Tumor Formation Induced by Transgenic Expression of ErbB2/neu
Cancer Res., May 1, 2002; 62(10): 2798 - 2805.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. E. Green, M.-A. Shibata, E. Shibata, R. C. Moon, M. R. Anver, G. Kelloff, and R. Lubet
2-Difluoromethylornithine and Dehydroepiandrosterone Inhibit Mammary Tumor Progression but not Mammary or Prostate Tumor Initiation in C3(1)/SV40 T/t-antigen Transgenic Mice
Cancer Res., October 1, 2001; 61(20): 7449 - 7455.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.